About Lykeion

Lykeion is a clinical-stage biopharma company dedicated to the design and delivery of personalized cancer vaccines for all patients based on certain knowledge of the individual's tumor targets and natural immune response.

With decades of combined experience in bioinformatics, immunology, and oncology, our team has the expertise and knowledge needed to accurately identify immunogenic mutations and target these as neoantigens